Novartis and Chai Discovery collaborate on antibody identification
The partnership is an extension of over 12 months of technical engagement between the two companies.
Drug Development
Cellares and Sonoma partner to automate cell therapy manufacturing
Takeda and Indonesia partner on plasma-derived therapies
FDA approves MSD’s Keytruda combinations for MIBC
Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar
Apertura and NIH institutes to test gene therapy for NPC1
Sino and AstraZeneca sign licence agreement for TQC3721
Evogene and Tel Aviv University launch drug discovery initiative
